Inactivating BTK mutations in large B‐cell lymphoma in a real‐world cohort: Strong correlation with BCL2 translocation

Inactivating mutations in Bruton's tyrosine kinase (BTK) in patients with follicular lymphoma (FL) have recently been reported. These mutations were found in BTK inhibitor‐treatment naïve patients. Here, we report the BTK mutation status in a real‐world cohort of patients with non‐Hodgkin lymph...

Descripción completa

Detalles Bibliográficos
Autores principales: Schejbel, Lone, Breinholt, Marie Fredslund, Gang, Anne Ortved, Nielsen, Torsten Holm, Pedersen, Lars Møller, Høgdall, Estrid, Nørgaard, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421985/
https://www.ncbi.nlm.nih.gov/pubmed/36051027
http://dx.doi.org/10.1002/jha2.489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421985/
https://www.ncbi.nlm.nih.gov/pubmed/36051027
http://dx.doi.org/10.1002/jha2.489

Ejemplares similares